RWE Across The Product Life Cycle: Regulatory And Payer Landscape

The shift towards a value-based, patient-centric approach to health care continues to increase the need to measure the impact of biopharma products and devices in a real world setting. Now more than ever, sponsors must understand the role real world evidence (RWE) can play in developing a product’s value story across the development continuum.

This webinar discusses how RWE is playing a larger role across the entire product lifecycle, with a focus on late phase regulatory discussions and payer decision-making.